TV commercial for Boston Scientific’s Watchman A-fib device

April 23, 2019- by Steven E. Greer, MD

This is actually a smart commercial. It will send shock waves throughout Big Pharma as those blood-thinner companies downplay bleeding as a mere “side effect”

For unknown reasons, this Watchman device has not been used much by the same cardiologists who overuse ineffective stents and push TAVR. They must not be getting a cut of the sales as they do with TAVR.

This entry was posted in - Medical Devices, Cardiac surgery, Cardiology, FDA. Bookmark the permalink.